Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 94

Results For "human"

1144 News Found

Experts point out key issues for vision loss at ASSOCHAM meet
Healthcare | February 24, 2022

Experts point out key issues for vision loss at ASSOCHAM meet

Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes


GSK introduces Haleon to the world
News | February 23, 2022

GSK introduces Haleon to the world

Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum


Vicore advances on new chemical entity from VP03 program
News | February 23, 2022

Vicore advances on new chemical entity from VP03 program

Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022


Bayer highlights pharma business plans on Media Day
News | February 23, 2022

Bayer highlights pharma business plans on Media Day

Robust pipeline with around 50 projects in clinical development / cardiology portfolio poised for growth with launch products Kerendia (finerenone) and Verquvo (vericiguat)


AstraZeneca partners with Honeywell to develop next-gen respiratory inhalers
Sustainability | February 22, 2022

AstraZeneca partners with Honeywell to develop next-gen respiratory inhalers

New inhalers would have near-zero Global Warming Potential propellant


Mental healthcare app heyy raises pre-seed funding
Startup | February 22, 2022

Mental healthcare app heyy raises pre-seed funding

US $ 555,000 invested by Wavemaker Partners in pre-seed round


IIT Delhi develops strategy for development of drug molecules
Biotech | February 21, 2022

IIT Delhi develops strategy for development of drug molecules

The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.


Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus
News | February 21, 2022

Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus

CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan


Moderna expands Its mRNA pipeline with new development programs
Biotech | February 20, 2022

Moderna expands Its mRNA pipeline with new development programs

These programs are: Herpes simplex virus (HSV) vaccine candidate, Varicella-zoster virus (VZV) vaccine candidate and Checkpoint cancer vaccine.


Indian pharma industry needs a winning partnership
News | February 19, 2022

Indian pharma industry needs a winning partnership

The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines